drug
testosterone enanthate
Marketedupdated 3mo agoby Antares Pharma Inc
Approvedcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying testosterone enanthate
- phase2Working Out M0 Bipolar Androgen Therapy
- phase352 Week Study + 24-Month Long-Term Extension of Safety, PK, & Efficacy of XYOSTED® for Testosterone Replacement in Male Adolescents With Hypogonadism
- phase2Testosterone and Olaparib in Treating Patients With Castration-Resistant Prostate Cancer
- phase4Testosterone Treatment for Erectile Dysfunction and Multiple Sclerosis
Patent cliff
source: FDA Orange Bookfirst barrier falls
Oct 4, 2026
53 days
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (69)
- Aug 30, 2038formulationUS 10646495
- Aug 30, 2038formulationUS 10646495
- Aug 30, 2038formulationUS 10646495
- Sep 4, 2036formulationUS 9950125
- Sep 4, 2036formulationUS 9950125
- Sep 4, 2036formulationUS 9950125
- Nov 19, 2035formulationUS 9744302
- Nov 19, 2035formulationUS 9744302
- Nov 19, 2035formulationUS 9744302
- Oct 18, 2035formulationUS 11191908
- Oct 18, 2035formulationUS 11191908
- Oct 18, 2035formulationUS 11191908
- Feb 25, 2035formulationUS 11813435
- Feb 25, 2035formulationUS 11813435
- Feb 25, 2035formulationUS 11813435
- Feb 19, 2035formulationUS 10238662
- Feb 19, 2035formulationUS 10238662
- Feb 19, 2035formulationUS 10238662
- Feb 19, 2035formulationUS 10912782
- Feb 19, 2035formulationUS 10912782
- Feb 19, 2035formulationUS 10912782
- Oct 7, 2034formulationUS 11160751
- Oct 7, 2034formulationUS 11160751
- Oct 7, 2034formulationUS 11160751
- Feb 11, 2034formulationUS 10881798
- Feb 11, 2034formulationUS 10881798
- Feb 11, 2034formulationUS 10881798
- Jun 4, 2033formulationUS 10821072
- Jun 4, 2033formulationUS 10821072
- Jun 4, 2033formulationUS 10821072
- Jun 4, 2033method-of-use (U-2418)US 11844804
- Jun 4, 2033method-of-use (U-2418)US 11844804
- Jun 4, 2033method-of-use (U-2418)US 11844804
- Aug 21, 2031formulationUS 10357609
- Aug 21, 2031formulationUS 10357609
- Aug 21, 2031formulationUS 10357609
- Aug 21, 2031formulationUS 10905827
- Aug 21, 2031formulationUS 10905827
- Aug 21, 2031formulationUS 10905827
- Aug 21, 2031formulationUS 11446440
- Aug 21, 2031formulationUS 11446440
- Aug 21, 2031formulationUS 11446440
- Jul 31, 2031formulationUS 102791315.0y
- Jul 31, 2031formulationUS 102791315.0y
- Jul 31, 2031formulationUS 102791315.0y
- Mar 19, 2030formulationUS 114977533.6y
- Mar 19, 2030formulationUS 114977533.6y
- Mar 19, 2030formulationUS 114977533.6y
- Oct 4, 2026formulationUS 802133553d
- Oct 4, 2026formulationUS 802133553d
- Oct 4, 2026formulationUS 802133553d
- Jan 24, 2026formulationUS 10478560
- Jan 24, 2026formulationUS 10478560
- Jan 24, 2026formulationUS 10478560
- Jan 24, 2026formulationUS 11446441
- Jan 24, 2026formulationUS 11446441
- Jan 24, 2026formulationUS 11446441
- Jan 24, 2026formulationUS 8562564
- Jan 24, 2026formulationUS 8562564
- Jan 24, 2026formulationUS 8562564
- Jan 24, 2026formulationUS 9180259
- Jan 24, 2026formulationUS 9180259
- Jan 24, 2026formulationUS 9180259
- Jan 24, 2026formulationUS 9533102
- Jan 24, 2026formulationUS 9533102
- Jan 24, 2026formulationUS 9533102
- Jan 24, 2026formulationUS 9629959
- Jan 24, 2026formulationUS 9629959
- Jan 24, 2026formulationUS 9629959
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 6m ago
Found something off?
comments(0)
5-min edit window · permanent after that